Everwell Health Holdings

Everwell Health Holdings is a consumer health and wellness platform established by the private equity firm RoundTable Healthcare Partners. The company focuses on the development, clinical validation, and commercialization of high-quality functional ingredients for the dietary supplement and functional food markets. Its foundational acquisition, Nutrition21, provides a robust portfolio of branded, scientifically backed ingredients including Nitrosigine, Chromax, and Lustriva. Everwell operates with a buy-and-build strategy, seeking to expand its reach through strategic partnerships and the acquisition of innovative ingredient technologies. The company's products target key health areas such as metabolic health, cognitive performance, and sports nutrition. By emphasizing rigorous clinical research, Everwell aims to provide its partners with ingredients that offer proven health benefits and consumer appeal.